RecruitingPhase 2NCT02559778
109
studies recruiting now
as of 7 Sept 2026
768
studies registered in total
as of 7 Sept 2026
25
countries with a recruiting site
as of 7 Sept 2026
7 Aug 2024
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 3NCT06172296
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingNCT01109394
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
RecruitingPhase 2NCT06540963
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
RecruitingPhase 1 / Phase 2NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 109 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Neuroblastoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Neuroblastoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (MYCN, LMO1, PHOX2B, ALK, HACE1, LIN28B).
Treatments being studied
6 approved treatments and 71 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Iobenguane I 131 (Azedra)Approved: Naxitamab (Danyelza)Approved: Melphalan (Alkeran)Approved: Dinutuximab Beta (Qarziba (previously dinutuximab beta eusa and dinutuximab beta apeiron))Approved: IobenguaneApproved: Dinutuximab (Unituxin)
Phase 3Thiotepa (Tepadina)
Phase 3Dacarbazine (Dacarbazine)
Phase 3Mesna (Mesna)
Phase 3Doxorubicin Hydrochloride (Adriamycin)
Phase 3Sargramostim (Leukine)
Phase 3Topotecan Hydrochloride (Evotopin)
Phase 3Cyclophosphamide (Cyclophosphamide)
Phase 3Etoposide Phosphate (Etopophos)
+ 63 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).